| Mr Daniel Allen Mesaros, CAA | |
|
100 Michigan St Ne, Grand Rapids, MI 49503-2560 | |
| (616) 364-4200 | |
| (616) 364-7347 |
| Full Name | Mr Daniel Allen Mesaros |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology Assistant |
| Experience | 16 Years |
| Location | 100 Michigan St Ne, Grand Rapids, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396996492 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Spectrum Health | Grand rapids, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Medical Consultants, Pc | 3678751658 | 87 |
| West Michigan Anesthesia Pc | 1355243551 | 193 |
News Archive
The U.S. Food and Drug Administration approved an important new inhaled antibiotic called Cayston® (aztreonam for inhalation solution) today for the treatment of cystic fibrosis. The drug was made possible by significant support from the Cystic Fibrosis Foundation, including a $1 million investment by a Foundation subsidiary to help develop the therapy.
Alere Analytics, an Alere subsidiary specializing in analytics and clinical decision support technology, today announced that Chief Medical Officer and Co-founder, Dr. Fauzia Khan will be presenting a keynote on Analytics and Health IT for the Population Health Management track at the fourth national Accountable Care Organization Summit on Friday, June 14 at 9 a.m.
Scientists at Case Western Reserve University and Vanderbilt University found that pulsed light can pace contractions in an avian embryonic heart, with no apparent damage to the tissue. The work, "Optical pacing of the embryonic heart," will be published in the advanced online issue of Nature Photonics on Aug. 15, 2010.According to the scientists, this non-invasive device may prove an effective tool in understanding how environmental factors that alter an embryo's heart rate lead to congenital defects. It may also lead to investigations of cardiac electrophysiology at the cellular, tissue and organ levels, and possibly the development of a new generation of pacemakers.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, today announced that on September 15, 2011, the U.S. Food and Drug Administration advised CorMedix, that the Center for Drug Evaluation and Research has been assigned as the lead agency for the pre-market review of Neutrolin.
› Verified 5 days ago
| Entity Name | West Michigan Anesthesia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225016926 PECOS PAC ID: 1355243551 Enrollment ID: O20040127000018 |
News Archive
The U.S. Food and Drug Administration approved an important new inhaled antibiotic called Cayston® (aztreonam for inhalation solution) today for the treatment of cystic fibrosis. The drug was made possible by significant support from the Cystic Fibrosis Foundation, including a $1 million investment by a Foundation subsidiary to help develop the therapy.
Alere Analytics, an Alere subsidiary specializing in analytics and clinical decision support technology, today announced that Chief Medical Officer and Co-founder, Dr. Fauzia Khan will be presenting a keynote on Analytics and Health IT for the Population Health Management track at the fourth national Accountable Care Organization Summit on Friday, June 14 at 9 a.m.
Scientists at Case Western Reserve University and Vanderbilt University found that pulsed light can pace contractions in an avian embryonic heart, with no apparent damage to the tissue. The work, "Optical pacing of the embryonic heart," will be published in the advanced online issue of Nature Photonics on Aug. 15, 2010.According to the scientists, this non-invasive device may prove an effective tool in understanding how environmental factors that alter an embryo's heart rate lead to congenital defects. It may also lead to investigations of cardiac electrophysiology at the cellular, tissue and organ levels, and possibly the development of a new generation of pacemakers.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, today announced that on September 15, 2011, the U.S. Food and Drug Administration advised CorMedix, that the Center for Drug Evaluation and Research has been assigned as the lead agency for the pre-market review of Neutrolin.
› Verified 5 days ago
| Entity Name | Anesthesia Medical Consultants, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063710689 PECOS PAC ID: 3678751658 Enrollment ID: O20110621000722 |
News Archive
The U.S. Food and Drug Administration approved an important new inhaled antibiotic called Cayston® (aztreonam for inhalation solution) today for the treatment of cystic fibrosis. The drug was made possible by significant support from the Cystic Fibrosis Foundation, including a $1 million investment by a Foundation subsidiary to help develop the therapy.
Alere Analytics, an Alere subsidiary specializing in analytics and clinical decision support technology, today announced that Chief Medical Officer and Co-founder, Dr. Fauzia Khan will be presenting a keynote on Analytics and Health IT for the Population Health Management track at the fourth national Accountable Care Organization Summit on Friday, June 14 at 9 a.m.
Scientists at Case Western Reserve University and Vanderbilt University found that pulsed light can pace contractions in an avian embryonic heart, with no apparent damage to the tissue. The work, "Optical pacing of the embryonic heart," will be published in the advanced online issue of Nature Photonics on Aug. 15, 2010.According to the scientists, this non-invasive device may prove an effective tool in understanding how environmental factors that alter an embryo's heart rate lead to congenital defects. It may also lead to investigations of cardiac electrophysiology at the cellular, tissue and organ levels, and possibly the development of a new generation of pacemakers.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, today announced that on September 15, 2011, the U.S. Food and Drug Administration advised CorMedix, that the Center for Drug Evaluation and Research has been assigned as the lead agency for the pre-market review of Neutrolin.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Daniel Allen Mesaros, CAA 3333 Evergreen Dr Ne, Grand Rapids, MI 49525-9493 Ph: (616) 364-4200 | Mr Daniel Allen Mesaros, CAA 100 Michigan St Ne, Grand Rapids, MI 49503-2560 Ph: (616) 364-4200 |
News Archive
The U.S. Food and Drug Administration approved an important new inhaled antibiotic called Cayston® (aztreonam for inhalation solution) today for the treatment of cystic fibrosis. The drug was made possible by significant support from the Cystic Fibrosis Foundation, including a $1 million investment by a Foundation subsidiary to help develop the therapy.
Alere Analytics, an Alere subsidiary specializing in analytics and clinical decision support technology, today announced that Chief Medical Officer and Co-founder, Dr. Fauzia Khan will be presenting a keynote on Analytics and Health IT for the Population Health Management track at the fourth national Accountable Care Organization Summit on Friday, June 14 at 9 a.m.
Scientists at Case Western Reserve University and Vanderbilt University found that pulsed light can pace contractions in an avian embryonic heart, with no apparent damage to the tissue. The work, "Optical pacing of the embryonic heart," will be published in the advanced online issue of Nature Photonics on Aug. 15, 2010.According to the scientists, this non-invasive device may prove an effective tool in understanding how environmental factors that alter an embryo's heart rate lead to congenital defects. It may also lead to investigations of cardiac electrophysiology at the cellular, tissue and organ levels, and possibly the development of a new generation of pacemakers.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, today announced that on September 15, 2011, the U.S. Food and Drug Administration advised CorMedix, that the Center for Drug Evaluation and Research has been assigned as the lead agency for the pre-market review of Neutrolin.
› Verified 5 days ago
Mr. Jeffrey Ryan Hall, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 3333 Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-364-4200 Fax: 616-364-7347 | |
Jason Dipman, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Michigan St Ne, Grand Rapids, MI 49503 Phone: 616-364-4200 | |
Meghan Fowler, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 3333 Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-364-4200 Fax: 616-364-7347 | |
Ms. Loredana Berkowitz, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 3333 Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-364-4200 Fax: 616-364-7347 | |
Andrea Mantel, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 3333 Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-284-3132 | |
Camille Meadows, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Michigan St Ne, Grand Rapids, MI 49503 Phone: 616-364-4200 Fax: 616-364-7347 | |
Mr. Lonnie Meadows, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Michigan St Ne, Grand Rapids, MI 49503 Phone: 616-364-4200 Fax: 616-364-7347 |